This compound is a pyrazole derivative featuring a boronic ester group. It is primarily utilized as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1282518-60-8
4,4-Difluoro-6-azaspiro[2.5]octane--hydrogen chloride (1/1)
pharmaceutical intermediate
4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole monohydrate
pharmaceutical intermediate
Methyl 6-(4-methoxyphenyl)-2-naphthoate
pharmaceutical intermediate
(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
pharmaceutical intermediate
1-Methyl-1H-pyrazole-5-boronic acid pinacol ester
pharmaceutical intermediate
Pyrazole-3-boronic acid pinacol ester
research compound
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazole
research compound
1-propan-2-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
ZKZJXVGTTZXHGX-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC=NN2C(C)C
—